Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FELQM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,975
Award facts
- Contract value 100% obligated
- $16,974.59 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,974.59 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 1, 2025, with an ultimate completion date of December 3, 2025, was issued without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products and medical consumables to Department of Defense healthcare facilities, including branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and emergency medications such as epinephrine auto-injectors and naloxone.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion government-wide acquisition strategy. The parent contract (SPE2DR), awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. DMS Pharmaceutical Group's established performance across numerous delivery orders demonstrates its capability to fulfill the diverse and specialized pharmaceutical requirements supporting Department of Defense military healthcare operations globally.
Quick answers
Who was awarded contract SPE2DU26FELQM?
SPE2DU26FELQM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 1, 2025.
How much is contract SPE2DU26FELQM worth?
The government has obligated $16,975 on SPE2DU26FELQM.
Is contract SPE2DU26FELQM an order under another contract?
Yes. SPE2DU26FELQM is a delivery order under SPE2DU25D9421, an indefinite delivery contract.
Was contract SPE2DU26FELQM competed?
The extent of competition for SPE2DU26FELQM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award